Pediatrics

For the approximately 2.4 million children and adolescents living with HIV today, managing health is a lifelong commitment that has traditionally relied on a daily three-drug regimen. While adults have recently benefited from simpler two-drug treatments,

A new animated video aimed at study participants explains what happens during a pharmacokinetics (PK) study. The video, which is now available to watch online in Lugandan,

FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) is pleased to announce two public-private partnerships. The first will accelerate the development of an investigational dispersible pediatric formulation containing emtricitabine and tenofovir alafenamide (F/TAF).